EndoMedia

Focus on Obesity The Society works to reduce prevalence of obesity. Explore our statements, guidelines, resources, and more.

Super Bowl ads are drawing attention to anti-obesity medications. Endocrinologists are at the forefront of obesity treatment and research: https://bit.ly/3yV6Ihc #SBLX #EndoSky #obesity

Insulin Levels Linked To Hot Flashes, Night Sweats In Menopause TUESDAY, Feb. 3, 2026 (HealthDay News) — Middle-aged women with elevated insulin levels might be in for a tougher menopause experience, a new study says.Women w

Women with elevated insulin levels face a higher risk of experiencing menopausal symptoms at a younger age, according to research published in #JCEM. Via @healthday.bsky.social @endocrinesociety.bsky.social @endosocjournals.bsky.social bit.ly/4bU1Myv #menopause #EndoSky

Enter the Endocrine Images Art Competition for a chance to win complimentary ENDO 2026 registration. The winning microscopy images will be displayed at ENDO and featured in Endocrine News: https://bit.ly/3htQ3ct #ENDO2026

New study directly links higher BMI to increased risk of vascular dementia; blood pressure may help explain why "What is good for the heart is good for the brain," one researcher says.

Research published in #JCEM explores how #obesity can raise dementia risk. Via ABC News: bit.ly/4pWF5gr @endocrinesociety.bsky.social @endosocjournals.bsky.social #EndoSky

Scientists discover new clue linking obesity to dementia risk European researchers trace a path that shows how high blood pressure caused by excess weight could be the link to certain cognitive brain disease.

Breaking news: #JCEM study finds new evidence for link between #obesity and dementia risk. Via @washingtonpost.com bit.ly/4r5ZJLM @endocrinesociety.bsky.social @endosocjournals.bsky.social #EndoSky

Do you need more testosterone? Answer: Probably not. Here's what to know.

Dr. Margaret Wierman describes the limited circumstances when testosterone should be prescribed to women in this interview with @19thnews.org's @jennifergerson.bsky.social. bit.ly/49HAg4f #menopause #EndoSky

Research shows most people need to remain on GLP-1 anti-obesity medications to maintain weight loss long term. Via @nytimes.com bit.ly/3YDFqcD #Endosky

Beyond the Needle: The Future of GLP-1 Pills and Other Emerging Obesity Treatments New drug candidates could transform the obesity treatment landscape again, as pill formulations and multi-agonist treatments undergo clinical trials. Endocrine Society experts Priya Jaisinghani, MD, DABOM, and Mehmet Furkan Burak, MD, discussed how emerging treatments could improve obesity treatment and provide new options for patients. Access additional obesity resources: https://bit.ly/3yV6Ihc Eli Lilly and Company provided support for this event.

Breaking news: @US_FDA approves first oral GLP-1 for weight loss. bit.ly/4b0XkNE

Watch our recent webinar for more on the rapidly evolving anti-obesity medication landscape. bit.ly/4pFHMn2 #EndoSky

Beyond the Needle: The Future of GLP-1 Pills and Other Emerging Obesity Treatments New drug candidates could transform the obesity treatment landscape again, as pill formulations and multi-agonist treatments undergo clinical trials. Endocrine Society experts Priya Jaisinghani, MD, DABOM, and Mehmet Furkan Burak, MD, discussed how emerging treatments could improve obesity treatment and provide new options for patients. Access additional obesity resources: https://bit.ly/3yV6Ihc Eli Lilly and Company provided support for this event.

How will obesity treatment evolve with the advent of GLP-1 pills and other emerging medications? Dr. Mehmet Furkan Burak and @drjayyy.bsky.social explored this during @endocrinesociety.bsky.social's Science Writers Conference. bit.ly/4pFHMn2 #EndoSky #MedSky

‘Everywhere chemicals’ are in our food, decades after scientists recognized dangers A large body of science has linked phthalates to a variety of serious health conditions, including premature birth and infertility.

New @washingtonpost.com article examines phthalates and how these endocrine-disrupting chemicals impact health. bit.ly/4oo1r9z #EDCs #EndoSky

FDA chief says warning labels deterred women from using menopause hormone therapy: "It's an American tragedy" In an interview with CBS News, FDA Commissioner Dr. Marty Makary explains what went into the decision to drop the most serious warnings on hormone therapy for menopause.

The U.S. Food and Drug Administration will remove the "black box" warning labels on many hormone therapy drugs used for menopause and perimenopause symptoms — a major turnaround that's likely to encourage more women to seek treatment.

Trump unveils deal to expand coverage and lower costs on obesity drugs President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy.

Breaking news: Trump announces deal to expand coverage and lower costs on anti-obesity medications. Via @apnews.com bit.ly/3WHyU3y #EndoSky

Alcohol, nicotine and more — could drugs like Ozempic curb the desire for vices? | CBC News Studies combing through past patient data have made a similar link between drugs like Ozempic and a loss of appetite for more than just food.

Researchers are exploring why anti-obesity medications may lessen cravings for alcohol. CBC News examines a recent review published in the Journal of the Endocrine Society. bit.ly/3L20VQH @endocrinesociety.bsky.social
@endosocjournals.bsky.social #EndoSky

Female Reproductive Health: ENDO 2025 | Oxytocin and Mood in Women with Disrupted Sleep The hormone oxytocin may shield women from mood disturbances when they face sleep disruptions in the postpartum transition or during menopause. Irene Gonsalvez, MD, describes the research she presented at ENDO 2025. “The higher the oxytocin levels the night before the sleep disruption was co-related with better mood the day after. The study results suggest that oxytocin may play a protective role and can help these women to lessen the adverse effects of estradiol suppression and sleep interruption that they have in their mood state.”— Irene Gonsalvez, MD

Abstract authors discuss findings of women’s reproductive health studies in our ENDO 2025 Research Highlights video series. The studies cover topics such as simultaneous use of menopausal hormone therapy (bit.ly/495czUQ) and anti-obesity medications (bit.ly/3JcnPnM) #ENDO2025 #endocrinology #EndoSky

Building muscle can protect against obesity-related complications, according to new research published in #JCEM. Via @wgntv.com bit.ly/496OblK @endocrinesociety.bsky.social @endosocjournals.bsky.social #EndoSky

Strong grip strength may protect against obesity-related complications People with excess body fat who build and keep muscle may be less likely to develop obesity-induced heart, liver, or kidney damage or die early, according to a new study published in The Journal of Cl...

Weak grip strength may signal who is most at risk of obesity-related complications, according to new research published in #JCEM. bit.ly/48rj3NE @endocrinesociety.bsky.social @endosocjournals.bsky.social #EndoSky

Member @smahalingaiahmd.bsky.social describes how NIH funding cuts stalled her research into air pollution and women’s reproductive health via @nytimes.com (bit.ly/4h6rWyo). Join our campaign to urge Congress to protect NIH research funding (bit.ly/4n0cl4B) (1/2) #EndoSky

GLP-1s show promise in treating alcohol and drug addiction A popular class of therapies for treating diabetes and obesity may also have the potential to treat alcohol and drug addiction, according to a new paper published in the Journal of the Endocrine Socie...

A class of anti-obesity medications also may have the potential to treat alcohol and drug addiction, according to a new paper published in the Journal of the Endocrine Society. bit.ly/4nCaLak @endocrinesociety.bsky.social #EndoSky

Trump slashed funding for universities that helped create these vital drugs Medications that prevent HIV, shrink tumors and treat seizures were invented with government funding. At research universities, that money is now canceled or in jeopardy.

Society member Joel Habener, MD, describes how NIH grants supported early research into the anti-obesity medication semaglutide. Via @washingtonpost.com. bit.ly/3IzUmUN @endocrinesociety.bsky.social #EndoSky

Michael Zitzmann, MD, PhD, discusses the connection between metabolic and reproductive health in older men in our #ENDO2025 video series. bit.ly/46oi7br #endocrinology #EndoSky

Men often delay seeking treatment for obesity, with serious health consequences. Via @nytimes.com bit.ly/4mjy4Ep #EndoSky

Sweetener Consumption and Early Puberty Risk | Certain sweeteners found in foods and beverages can raise the risk of early puberty in children. Yang-Ching Chen, MD, PhD, explains the research she presented at ENDO: bit.ly/3W0s2h7 #ENDO2025 #endocrinology #EndoSky #puberty

How can we address the widespread problem of childhood #obesity identified in the new @unicef.org report? Shirley Hao, MD, explores the issue in the @endocrinesociety.bsky.social's video series. bit.ly/4gk3Dg9 #EndoSky

ENDO 2025 Research Explores Endocrine Aspects of Aging | Abstract authors share details on their ENDO research on aging. The studies explore the benefits of osteoporosis treatment for patients 80 years and older as well as the impact of social isolation on diabetes risk: bit.ly/47IO2EF #ENDO2025

Endocrine Society honors endocrinology field’s leaders with 2026 Laureate Awards The Endocrine Society today announced it has chosen 12 leading endocrinologists as winners of its prestigious 2026 Laureate Awards, the top honors in the field.

Congratulations to the @endocrinesociety.bsky.social's 2026 Laureate Award winners! bit.ly/4pgssxv #EndoSky

The health risks from plastics almost nobody knows about Researchers have linked phthalates, chemicals found in plastics, to premature birth, infertility and ADHD.

Endocrine-disrupting chemicals experts discuss the health risks posed by chemicals found in plastics. Via @washingtonpost.com bit.ly/3K4x5KJ @leotrasande.bsky.social @endocrinesociety.bsky.social #EndoSky

People who skip breakfast and eat late dinners may have a higher risk of osteoporosis People who skip breakfast and eat late dinners may have an increased risk of developing osteoporosis, according to a new study published in the Journal of the Endocrine Society.

Skipping breakfast and eating late dinners may raise the risk of osteoporosis, according to new research study. bit.ly/4mLfVRa @endocrinesociety.bsky.social @endosocjournals.bsky.social #EndoSky

Explore the ENDO 2025 press release topics including adrenal insufficiency, anti-obesity medications, type 2 diabetes, puberty, hypothyroidism, and more. Stay tuned for select video interviews with abstract authors from these press releases: bit.ly/2wMKFNL #ENDO2025
@endomedia.bsky.social

Obesity Prediction Could Be Guided by Genetic Risk Scores Researchers hope that a better understanding of which genes contribute to excess weight could help with prevention starting in childhood.

Obesity prediction could be guided by genetic scores. Via @nytimes.com bit.ly/4m7KdN #endosky

Hypothyroidism Linked to Gut Microbiome Disturbances Novel research shows an increased risk for small intestinal bacterial overgrowth in people with hypothyroidism, even after treatment.

News from #ENDO2025 from @medscape.com: Research finds hypothyroidism is linked to gut microbiome disturbances. wb.md/3TT0OYY @endocrinesociety.bsky.social #endosky #thyroid